en es frdeSE

Wissenschaftliches Material

570 bisher veröffentlichte Artikel mit Peer Review

2023
Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review

Clinical remission / combination / comorbidity / Dermatology / elderly / extraintestinal manifestations / gma / Immunosuppressant / infections / Pyoderma gangrenosum / refractory / Safety / severe / ulcerative colitis / vedolizumab /
Weiterlesen
2023
Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review

https://pubmed.ncbi.nlm.nih.gov/37928629/

Pyoderma gangrenosum in ulcerative colitis patient treated with vedolizumab: adsorptive granulocyte/monocyte apheresis as a new therapeutic option refractory cases – a case report and literature review – PMC (nih.gov)

case report / combination / efficacy / EIM / Frail / gma / intensive / Pyoderma gangrenosum / Safety / ulcerative colitis / vedolizumab /
Weiterlesen
2023
Treatment Strategies in Neutrophilic Dermatoses: A Comprehensive Review

https://pubmed.ncbi.nlm.nih.gov/37958609/

https://www.mdpi.com/1422-0067/24/21/15622

Dermatology / generalized pustular psoriasis / gma / neutrophil / neutrophilic dermatoses / vasculitis /
Weiterlesen
2023
Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update

alternative / anti-TNFα / biologics / complementary / gma / IBD / Jak inhibitors /
Weiterlesen
2023
Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis (UC): evidence from a systematic literature review (SLR)

ASUC / Clinical remission / cohort / cyclosporine / efficacy / gma / golimumab / Infliximab / moderate to severe / Multicenter / observational / Safety / steoids / study / systematic literature review / Tacrolimus / tofacitinib / ulcerative colitis / Ustekinumab / vedolizumab /
Weiterlesen
2023
Severe and refractory gastrointestinal toxicity due to immune checkpoint inhibitors: clinical experience in a tertiary referral hospital

enterocolitis / gastritis / gma / immune checkpoint inhibitors / Infliximab / microscopic colitis / observational / Refractory patients / RETROSPECTIVE / steroids / study / ulcerative colitis / Ustekinumab / vedolizumab /
Weiterlesen
2023
Adsorptive cytapheresis in ulcerative colitis: A non-pharmacological therapeutic approach revisited

elderly / gma / high-risk patients / Loss of response / partial response / positionning / Safety / steroid dependent / ulcerative colitis /
Weiterlesen
2023
A case report on cotrimoxazole-induced Sweet syndrome – a dermatological dilemma

https://journals.co.za/doi/abs/10.10520/ejc-mp_sapj_v90_n5_a12

cotrimoxazole / Dermatology / gma / neutrophil infiltration / neutrophilic dermatoses / steroid / Sweet's syndrome /
Weiterlesen
2023
Successful Use of Granulocyte and Monocyte Adsorptive Apheresis in a Patient with Post-COVID-19 Multisystem Inflammatory Syndrome in Adults

Covid-19 / gma / immunoglobulin / MIS-A / Multisystem inflammatory syndrome / myocarditis / pericarditis / steroid /
Weiterlesen
2023
Sarcopenia and treatment failure in inflammatory bowel disease: a systematic review and meta-analysis

https://online.reed.es/DOI/PDF/ArticuloDOI_9808.pdf

concomitant drugs / gma / IBD / Safety / surgery / treatment -resistant /
Weiterlesen
2023
Intensive Frequent Granulocyte Adsorptive Apheresis Therapy for Acute Fulminant Ulcerative Colitis: Two Consecutive Case Reports

Acute / case report / Clinical remission / daily sessions / fulminant / gma / intensive / rapid efficay / Refractory patients / ulcerative colitis /
Weiterlesen
2023
Intracellular DNA sensing by neutrophils and amplification of the innate immune response

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1208137/full

gma / innate immunity / neutrophil / plaque skin lesions / Psoriasis /
Weiterlesen

3
4
5
6
7
8

KontaktWeitere Informationen

Kontakt